S.Biomedics Co., Ltd. (KOSDAQ:304360)
South Korea · Delayed Price · Currency is KRW 30,650
-1,650 (-5.11%)
At close: Feb 6, 2026
S.Biomedics Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -9,576 | -6,691 | -10,321 | -6,327 | -5,667 | -7,747 |
Depreciation & Amortization | 1,958 | 1,725 | 1,553 | 1,517 | 1,448 | 1,349 |
Loss (Gain) From Sale of Assets | - | - | -5.49 | - | - | - |
Asset Writedown & Restructuring Costs | 50 | - | - | - | - | - |
Loss (Gain) From Sale of Investments | -119.78 | -25.23 | -51.81 | -6.77 | -0.24 | -89.31 |
Stock-Based Compensation | 312.93 | 55.38 | 86.21 | 148.08 | 217.39 | 326.65 |
Provision & Write-off of Bad Debts | 322.88 | 12.67 | 174.99 | -160.05 | -188.31 | 447.77 |
Other Operating Activities | 3,701 | 1,856 | 4,564 | 3,105 | 1,666 | -214.12 |
Change in Accounts Receivable | 127.25 | 201.51 | -771.8 | -697.48 | 440.6 | -417.1 |
Change in Inventory | 649.76 | 71.14 | -830.05 | -817.71 | -204.21 | -45.37 |
Change in Accounts Payable | -177.16 | -292.73 | 63.31 | 379.86 | -423.02 | -63.87 |
Change in Other Net Operating Assets | -3,642 | -413.31 | -610.69 | -347.05 | -576.36 | 1,016 |
Operating Cash Flow | -6,394 | -3,500 | -6,149 | -3,205 | -3,287 | -5,437 |
Capital Expenditures | -1,287 | -1,390 | -1,847 | -9,295 | -474.49 | -182.63 |
Sale of Property, Plant & Equipment | - | - | 22.14 | - | - | - |
Sale (Purchase) of Intangibles | -324.4 | -324.4 | - | -149.39 | -15.8 | -6.81 |
Investment in Securities | -5,149 | -8,547 | -6,655 | 2,708 | -3,445 | 8,996 |
Other Investing Activities | -108.04 | -86 | -343.25 | -43.69 | -64.87 | -8.56 |
Investing Cash Flow | -7,069 | -10,348 | -8,824 | -6,871 | -3,990 | 8,788 |
Long-Term Debt Issued | - | 11,775 | - | 7,000 | 4,860 | 1,400 |
Total Debt Issued | 11,775 | 11,775 | - | 7,000 | 4,860 | 1,400 |
Short-Term Debt Repaid | - | - | - | - | - | -138.5 |
Long-Term Debt Repaid | - | -2,573 | -1,156 | -732.69 | -1,061 | -446.73 |
Total Debt Repaid | -2,777 | -2,573 | -1,156 | -732.69 | -1,061 | -585.23 |
Net Debt Issued (Repaid) | 8,998 | 9,202 | -1,156 | 6,267 | 3,799 | 814.93 |
Issuance of Common Stock | 1,377 | 7,574 | 14,282 | - | - | 52.5 |
Other Financing Activities | 373.53 | 133.5 | -808.56 | 852.9 | 362.18 | 144.46 |
Financing Cash Flow | 10,748 | 16,909 | 12,318 | 8,020 | 4,161 | 2,432 |
Foreign Exchange Rate Adjustments | 13.21 | 11.89 | -0.86 | -9.47 | 59.35 | -20.4 |
Net Cash Flow | -2,701 | 3,074 | -2,656 | -2,066 | -3,057 | 5,763 |
Free Cash Flow | -7,681 | -4,890 | -7,996 | -12,501 | -3,762 | -5,620 |
Free Cash Flow Margin | -45.28% | -35.61% | -61.00% | -103.20% | -42.42% | -105.65% |
Free Cash Flow Per Share | -650.07 | -425.15 | -731.44 | -1223.19 | -370.56 | -555.91 |
Cash Interest Paid | 364.94 | 426.59 | 487.05 | 156.16 | 158.4 | 184.78 |
Cash Income Tax Paid | 145.37 | 78 | 31.47 | 3.22 | -20.09 | -16.97 |
Levered Free Cash Flow | -3,208 | -4,647 | -8,051 | -9,322 | -3,057 | -3,832 |
Unlevered Free Cash Flow | -2,711 | -4,150 | -7,499 | -8,867 | -2,636 | -3,510 |
Change in Working Capital | -3,042 | -433.4 | -2,149 | -1,482 | -762.99 | 489.64 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.